Fadia Najjar Bashore

Title: Fadia Najjar Bashore: Innovator in Pharmaceutical Formulations

Introduction: Fadia Najjar Bashore is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the stabilization of complex compounds. Her work is characterized by a commitment to enhancing the efficacy and safety of medications.

Latest Patents: Fadia Najjar Bashore holds 1 patent for her invention titled "Stabilized formulations of 6-hydroxy-3-(-4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof." This patent focuses on pharmaceutical formulations that incorporate stabilizing agents such as methionine, acetylcysteine, and cysteine to prevent oxidation and decomposition of the active compound.

Career Highlights: Fadia is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves research and development of innovative drug formulations that aim to improve patient outcomes. Her expertise in pharmaceutical chemistry has positioned her as a valuable asset to her team.

Collaborations: Fadia Najjar Bashore has collaborated with notable colleagues, including Kerry John Hartauer and Michael Dean Minnett. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion: Fadia Najjar Bashore's contributions to pharmaceutical formulations exemplify her dedication to advancing medical science. Her innovative work continues to impact the field positively, ensuring safer and more effective treatments for patients.